We are on an exciting journey. Keep up with us as we grow!
Born of a multidisciplinary collaboration between biologists and physicist at the University of Durham, UK, Magnitude Biosciences has expanded from an automated imaging spin-off to a fully-fledged pre-clinical contract services provider. Here’s what we’ve been up to along the way!
2020-10: CONFERENCE NEWS! Magnitude Biosciences is coming to . Access our and for an overview of our ageing, neurodegenration and microbiome assays.
2020-10: CONFERENCE NEWS! Magnitude Biosciences CEO, David Weinkove, has been confirmed as a Keynote speaker for the . Check out the !
2020-08: FUNDING AWARDED! Magnitude Biosciences secures UK government Future Fund to expand its workforce. Read our !
2020-06: CONFERENCE NEWS! Magnitude Biosciences will be presenting at the . Check out our !
2020-05: KEEP YOUR PROJECT GOING! Magnitude Biosciences' new is fully operational and we are ready to support your research!
2020-05: NEW SERVICES! Magnitude Biosciences now offers after acquiring Invermis Ltd.
2020-05: MICROBIOME WEBINAR! Listen to our CEO, Dr. David Weinkove, explain how Magnitude Biosciences' technology can help researchers in the field.
2020-03: CONFERENCE NEWS! Magnitude Biosciences will be pleased to attend , co-ordinated from the Sorbonne, Paris.
2019-12: FUNDING AWARDED! Magnitude Biosciences secures its second round of funding to support its pre-clinical research services.
2019-01: LAUNCH! Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham University, UK.